Made For Sufferers, By Sufferers
We know how hard it is to live with inflamed skin conditions while struggling to find effective but safe non-Rx solutions. It's why we created the Bodewell range of clinical plant-based treatments and gentle cleansers. Our products are designed to treat and manage the symptoms associated with mild-to-moderate eczema, psoriasis, and sensitive skin - including itching, redness, burning, dryness, flaking, and irritation.
There are two types of people in this world. Those with clear skin, and
of people suffer with sensitive skin
Time for change.
I have suffered from severe eczema for 30 years, and when I moved to the USA I realized just how many people do not have access to effective solutions and education for eczema, psoriasis, and compromised skin. With all the incredible clinical advancements of our era, this is really not good enough. We want to change the current dynamic, and we started Bodewell to do just that. We have begun with clinical, plant-powered, and efficacious treatments for mild-to-moderate eczema, psoriasis, and inflamed skin, and for us, it's just the beginning.
Anchored in innovation, science, and efficacy
Our products are all anchored in innovation, science, and efficacy, with our plant-based treatments subject to double-blind clinical patient trials. With so many options available to customers who live with skin conditions, we only focus on new technology that is shown to provide meaningful improvements and outcomes for most sufferers - not the recycled existing technology which dominates the existing OTC market.
A holistic view to treatment
Topical treatments are one key ingredient to skin flare management and to breaking the flare-cycle, but not the only one. Lifestyle changes such as stress reduction and emotional management can have a profound physiological impact. We know that there are no magic bullets or cures, so alongside our treatments we offer education for yogic breathing exercises and other stress reduction tools that have helped us on our own journeys.
World-class ingredients, USA production
We work with the best partners worldwide to source our ingredients. Our plants are sourced from a global network of suppliers that meet or exceed FDA/HPUS/AHPA/USP ID standards; these qualified suppliers are throughout Europe, Asia, and North America, including: Germany, France, and the Netherlands. Rigorous quality control testing is conducted at a USA-based, cGMP compliant, and FDA registered OTC drug manufacturing lab, including: plant sampling and verification, microbial contamination testing, heavy metal testing, and bio-activity testing. Our product is also manufactured and bottled at a USA-based, cGMP compliant, and FDA registered OTC drug manufacturing facility.
Our Dermatologist Leadership Team
Tiffany Mayo, M.D. is a board-certified dermatologist and Assistant Professor of Dermatology at The University of Alabama at Birmingham. She received an undergraduate and master’s degree in Chemistry at Tuskegee University. Dr. Mayo completed her medical degree from Baylor College of Medicine and Dermatology training at The University of Alabama at Birmingham. She is the Director of Dermatology Clinical Research and her clinical interests include skin of color, inflammatory diseases, including atopic dermatitis and psoriasis, and hair and scalp disorders
Peter Lio, M.D. is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Lio received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and a founding partner of Medical Dermatology Associates of Chicago. He currently serves as a board member and scientific advisory committee member for the National Eczema Association and has over 150 publications and two textbooks.
Smita Aggarwal, M.D. is a board-certified dermatologist and board-certified pediatric dermatologist. She received her medical degree from the University of Kansas, completed her Dermatology training at Loyola University Medical Center in Chicago, followed by a Pediatric Dermatology fellowship at Lurie Children’s Hospital, affiliated with Northwestern University. She is a Fellow of the American Academy of Dermatology, member of the Chicago Dermatological Society, and the Society for Pediatric Dermatology. Her clinical interests include autoimmune and inflammatory diseases in both the adult and pediatric population, with a focus on atopic dermatitis and psoriasis. She currently practices in downtown Chicago, where she aims to integrate both traditional and complementary treatments in her practice of medicine.
Dr. Silverberg completed his undergraduate and medical school training as a part of the highly selective dual B.A./M.D. program at State University of New York Downstate Medical Center, in Brooklyn. He also received his doctorate in neuroimmunology and Master of Public Health degree in biostatistics and epidemiology from the State University of New York Downstate Medical Center.
Dr. Silverberg’s area of clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. His publications include more than 600 peer-reviewed articles, abstracts and book chapters and he is known internationally for his work.
He is also an associate editor for the Journal of the American Academy of Dermatology, British Journal of Dermatology and Current Dermatology Reports. Dr. Silverberg is a member of the International Eczema Council, North American Contact Dermatitis Group the American Society of Contact Dermatitis. Dr. Silverberg is also the chair of the annual Revolutionizing Atopic Dermatitis global multidisciplinary conference.